Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
Rhea-AI Summary
Merit Medical Systems (NASDAQ:MMSI) will release its second quarter 2026 financial results for the period ended June 30, 2026, after market close on Thursday, July 30, 2026. An investor conference call will follow at 4:30 p.m. Eastern, with webcast and registration links available at www.merit.com.
Positive
- None.
Negative
- None.
News Market Reaction – MMSI
In the Jul 6 session, MMSI gained 0.51%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 02 | Earnings date notice | Neutral | +0.2% | Scheduled release of Q1 2026 results with same-day investor call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Tag-specific history is limited, with one prior earnings date notice showing a small move.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH JORDAN, Utah, July 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2026, after the close of the stock market on Thursday, July 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, July 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).
To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.
A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.
ABOUT MERIT
Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,500 people worldwide.
| Contacts: | |
| PR/Media Inquiries: Sarah Comstock Merit Medical | Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare |
| +1-801-432-2864 | +1-443-213-0509 |
| sarah.comstock@merit.com | mike.piccinino@icrhealthcare.com |